Human malignant melanomas express receptors for luteinizing hormone releasing hormone allowing targeted therapy with cytotoxic luteinizing hormone releasing hormone analogue. (Q40402230)

From Wikidata

Jump to navigation Jump to search

scientific article published on July 2005

Language	Label	Description	Also known as
English	Human malignant melanomas express receptors for luteinizing hormone releasing hormone allowing targeted therapy with cytotoxic luteinizing hormone releasing hormone analogue.	scientific article published on July 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15994963%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Human malignant melanomas express receptors for luteinizing hormone releasing hormone allowing targeted therapy with cytotoxic luteinizing hormone releasing hormone analogue (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15994963%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15994963%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15994963%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

7

object named as

Gabor Halmos

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15994963%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

3

object named as

Timo Gaiser

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15994963%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1

object named as

Gunhild Keller

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15994963%20AND%20SRC:MED&resulttype=core&format=json

author name string

Attila Nagy

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15994963%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Benjamin Baker

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15994963%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Gabriela Westphal

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15994963%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

language of work or name

0 references

publication date

1 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15994963%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Cancer Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15994963%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

65

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15994963%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15994963%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

5857-5863

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15994963%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Systemic chemotherapy in the treatment of malignant melanoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Targeted cytotoxic analogue of luteinizing hormone-releasing hormone (LH-RH) only transiently decreases the gene expression of pituitary receptors for LH-RH.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Cancer statistics, 2004

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Classical chemotherapy for metastatic melanoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Targeted approaches to cancer therapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

A conjugate of doxorubicin and an analog of Luteinizing Hormone-Releasing Hormone shows increased efficacy against oral and laryngeal cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Adjuvant therapy of cutaneous melanoma: the interferon debate.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Cytotoxic analogs of luteinizing hormone-releasing hormone bind with high affinity to human breast cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Antitumor effects of the cytotoxic luteinizing hormone-releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Monoclonal antibody drug immunoconjugates for targeted treatment of cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

UICC/CRC conference on targeted cancer therapy. Royal Free Hospital School of Medicine, London, December 17-19, 1991

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Inhibition of human hepatocarcinoma cell proliferation by mammalian and fish gonadotropin-releasing hormones

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Targeted cancer therapy with gonadotropin-releasing hormone chimeric proteins

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Recent Trends in Cutaneous Melanoma Incidence Among Whites in the United States

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

The role of biological response modifiers in malignant melanoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Dimethyl triazeno imidazole carboxamide and combination therapy for melanoma. IV. Late results after complete response to chemotherapy (Central Oncology Group protocols 7130, 7131, and 7131A)

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

An overview of targeted treatments in cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Chemotherapy targeted to cancers through tumoral hormone receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Locally Expressed LHRH Receptors Mediate the Oncostatic and Antimetastatic Activity of LHRH Agonists on Melanoma Cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Membrane receptors for peptides in experimental and human pancreatic cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Effects of luteinising-hormone-releasing hormone on nervous-system tumours

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-04-3816

Identifiers

10.1158/0008-5472.CAN-04-3816

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15994963%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15994963%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40402230&oldid=2119230723"